ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells

BACKGROUND: Chemotherapy resistance is the leading cause of cancer treatment failure. This research was conducted to explore a potential link between actin-binding protein anillin (ANLN) and doxorubicin resistance in breast cancer. MATERIALS AND METHODS: We compared ANLN expression and 50% inhibitio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Xiang, Zhen, Huang, Teng, Zhang, Min, Zhou, Wei-Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548225/
https://www.ncbi.nlm.nih.gov/pubmed/33116832
http://dx.doi.org/10.2147/CMAR.S261828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548225/
https://www.ncbi.nlm.nih.gov/pubmed/33116832
http://dx.doi.org/10.2147/CMAR.S261828

Ejemplares similares